Back

Deciphering the effect of exercise timing on glucose metabolism: a randomised controlled trial

3 April 2025 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Managing diabetes and glucose metabolism Public Health EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Ms Fabienne Bruggisser

Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Proteomic screening using NGS-based method identifies cardiovascular diseases biomarkers in patients without cardiovascular disease but with glucose metabolism disturbances.
Professor K. Kaminski (Bialystok, PL)
Abstract Slides
Presentation thumbnail
Exploring the preventive role of GLP-1 receptor agonists in reducing pulmonary hypertension in diabetes: a multimodal analysis
Doctor A. Albulushi (Muscat, OM)
Abstract Slides
Presentation thumbnail
Effect of SGLT2 inhibitors on temporal change of skeletal muscle index in patients with outpatient cardiac rehabilitation program
Doctor M. Kanazawa (Morioka, JP)
Abstract Slides
Presentation thumbnail
Application and usability of telemonitoring devices and Apps for patients with heart failure and diabetes type II.
Doctor S. Scalvini (Lumezzane, IT)
Abstract Slides
Presentation thumbnail
Non-invasive continuous glucose monitoring in patients without diabetes: use in cardiovascular prevention - a systematic review
Ms G. Petrasch (Davos Wolfgang, CH)
Abstract Slides

Access the full session

Session thumbnail
Managing diabetes and glucose metabolism

The Event

Event poster

ESC Preventive Cardiology 2025

3 April 2025 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Cost-effectiveness of HerzMobil Tirol, a multidimensional post-discharge disease management program for heart failure patients Economic evaluation along a one-year observation period
thumbnail
Congress Session
Evolutions in arrythmia and syncope management
thumbnail
Congress Presentation
Newcard telemonitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the French National Health Data System

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources